Liminatus Pharma logo

Liminatus Pharma

LIMN | NASDAQ
Chart Builder DCF Calculator
$3.04
+$0.05 (+1.67%)
At close: Nov 16, 2026, 3:59 PM ET
$2.99
-$0.05 (-1.58%)
After-hours: Nov 16, 2026, 7:41 PM ET
+1.67%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
10.8
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #1018/1021 (Top 100%)

Key Statistics

Market Data

Market Cap $4.08M
1D Range
2.92 3.13
52W Range
2.52 102.50

Valuation (TTM)

PE -0.13
PB 13.58
EV/EBITDA -0.20

Valuation (NTM)

Forward PE N/A
Forward PEG -0.00
Price Target $0.00
Loading financial charts...

Profile

Liminatus Pharma, Inc. is an immuno-oncology firm, currently in its clinical development phase, dedicated to pioneering new treatments for cancer. The company's headquarters are located in La Palma, C...

Sector Healthcare
Industry Biotechnology
Employees 1
IPO Date May 1, 2025
Fiscal Year January - December

Latest News

No news articles available yet.

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.